• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Hill-Rom Holdings

Siemens Healthineers and Hill-Rom team up to provide diabetes tools to primary care providers

May 7, 2018 By Sarah Faulkner

Siemens Healthineers (NYSE:SI) and Hill-Rom (NYSE:HRC) inked a co-marketing agreement to provide an array of point-of-care diagnostic instruments for diabetes to primary healthcare providers in the U.S. The offering is slated to include Siemens’ DCA Vantage Analyzer for HbA1c testing, the Clinitek Status+ Urine Chemistry Analyzer for kidney testing and Hill-Rom’s Welch Allyn RetinaVue Network and imaging tech […]

Filed Under: Diabetes, Diagnostics, Featured, Hospital Care, Wall Street Beat Tagged With: Hill-Rom Holdings, Siemens

Study: Hill-Rom’s Metaneb System lowers risk of post-operative pulmonary complications

February 28, 2018 By Sarah Faulkner

Hill-Rom's Metaneb system

Researchers at the 47th Society of Critical Care Medicine reported this week that Hill-Rom‘s (NYSE:HRC) Metaneb System may help reduce the incidence of post-operative pulmonary complications in high-risk patients. A 419-patient study found that patients using the Metaneb System combined with standard respiratory therapy spent 1.6 fewer days in the hospital on average compared to […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Respiratory, Surgical, Wall Street Beat Tagged With: Hill-Rom Holdings

Keeping a patient’s lungs clean & expanded after surgery: a Drug Delivery Business News podcast

September 25, 2017 By Sarah Faulkner

Hill-Rom's Metaneb system

Every year, more than 1 million patients in the U.S. find themselves suffering from respiratory complications following surgery, according to Hill-Rom (NYSE:HRC). These complications come at a cost – to both the patient and the hospital. A respiratory problem can increase a patient’s time in the hospital by as much as 89%. More people die each […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Respiratory Tagged With: Hill-Rom Holdings

Medtech stories we missed this week: July 21, 2017

July 21, 2017 By Danielle Kirsh

missed medtech

From Second Sight’s South Korean market entry to Sanuwave’s Indonesian distribution deal, here are medtech stories we missed this week but thought were still worth mentioning. 1. Second Sight enters South Korea market Second Sight announced in a July 5 press release that it has entered the market in South Korea with the implantation of two […]

Filed Under: Clinical Trials, Diagnostics, Featured, Food & Drug Administration (FDA), Implants, Regulatory/Compliance, Surgical Tagged With: Alpha Tau Medical, ApiFix, Hill-Rom Holdings, medtech, Mitsubishi, Reha Technology, Sanuwave Health, Second Sight

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS